Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED)

This study has been terminated.
(The overall profile does not support development for obesity)
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: August 16, 2005
Last updated: February 4, 2015
Last verified: February 2015